133 related articles for article (PubMed ID: 35045510)
1. [A Case of HER2-Positive Gastric Cancer with Multiple Lung and Liver Metastases Showing Long-Term Survival].
Fujimori D; Tsuneda A; Kurata T; Shoji Y; Kadoya N
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2115-2117. PubMed ID: 35045510
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Stage Ⅳ Gastric Cancer with Multiple Liver Metastases, Resected Primary Tumor after Chemotherapy, and Alive for 3.5 Years without Recurrence].
Nakagawa T; Yamamoto Y; Yanagawa S; Shiozaki S; Kaneko Y; Watanabe A; Nishina M; Takei D; Sumi Y; Yamaki M; Kurayoshi M; Hashizume J; Oshita A; Nakahara M; Noriyuki T
Gan To Kagaku Ryoho; 2024 Apr; 51(4):433-435. PubMed ID: 38644313
[TBL] [Abstract][Full Text] [Related]
3. [A Case of HER2 Positive Unresectable Gastric Cancer Leading to Conversion Therapy with Chemotherapy].
Amagasa H; Fukuda A; Iida S; Tokairin Y; Imai K; Ganno H; Maeda F; Kawamura Y; Kawaguchi M; Kajiyama D; Tanahashi T; Itakura K; Akuta S; Ando M
Gan To Kagaku Ryoho; 2021 Apr; 48(4):593-595. PubMed ID: 33976059
[TBL] [Abstract][Full Text] [Related]
4. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
Hirata K; Hamamoto Y; Ando M; Imamura CK; Yoshimura K; Yamazaki K; Hironaka S; Muro K
BMC Cancer; 2020 Jun; 20(1):548. PubMed ID: 32532230
[TBL] [Abstract][Full Text] [Related]
5. [Two Cases of HER2-Positive Gastric Cancer with Multiple Liver Metastases Leading to Conversion Therapy with Chemotherapy].
Ono HA; Kaneshiro M; Nakashima M; Baba H; Abe T; Kumagai J; Sugita M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1662-1664. PubMed ID: 29394735
[TBL] [Abstract][Full Text] [Related]
6. Successful second conversion surgery after trastuzumab deruxtecan for recurrent HER2-positive gastric cancer.
Terashima T; Yamashita T; Takabatake H; Nakanuma S; Kinoshita J; Yagi S; Mizukoshi E; Harada K; Fushida S; Kaneko S
Clin J Gastroenterol; 2023 Jun; 16(3):330-335. PubMed ID: 36708503
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Recurrent Gastric Cancer of Multiple Organ Metastasis with Long-Term Survival Due to Multimodal Treatment].
Hasegawa T; Kubo N; Sakurai K; Kuroda K; Tashima T; Iseki Y; Murata A; Nishii T; Kodai S; Tachimori A; Shimizu S; Kanazawa A; Inoue T; Nishiguchi Y; Maeda K
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1730-1732. PubMed ID: 36732981
[TBL] [Abstract][Full Text] [Related]
8. [Remarkable Response to Trastuzumab Observed in a Case of Gastric Cancer with HER2-Negative Conversion].
Horii N; Morioka D; Yamaguchi K; Sato Y
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1207-1209. PubMed ID: 27760939
[TBL] [Abstract][Full Text] [Related]
9. [A Case of HER2-Positive Advanced Gastric Cancer with Multiple Liver Metastases Effectively Treated with Trastuzumab, Capecitabine, and Cisplatin Combination Therapy].
Kuga Y; Kitamura S; Okanobu H; Sakimoto H; Nishida T
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1211-1214. PubMed ID: 27760940
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Complete Response to Trastuzumab plus S-1 and Oxaliplatin for a HER2-Positive Recurrence of Gastric Cancer].
Kitayama Y; Sugimoto T; Ishikawa H; Yoden Y
Gan To Kagaku Ryoho; 2018 Dec; 45(12):1743-1746. PubMed ID: 30587732
[TBL] [Abstract][Full Text] [Related]
11. [A Case of Advanced Gastric Cancer with Simultaneous Liver Metastasis for Long-Term Survival with Multimodal Therapy].
Sugimura K; Masuzawa T; Katsuyama S; Shinke G; Ikeshima R; Kawai K; Hiraki M; Katsura Y; Omura Y; Hata T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2023 Mar; 50(3):396-398. PubMed ID: 36927921
[TBL] [Abstract][Full Text] [Related]
12. [A Case of HER2-Positive Gastric Cancer with Multiple Liver Metastases Treated with Curative Conversion Therapy after Chemotherapy].
Kato Y; Natsuki S; Iimori N; Okuno T; Kametani N; Noda E; Yamamoto A; Yamada N; Nishimura S; Taenaka N; Matsunaga Y; Fujita S
Gan To Kagaku Ryoho; 2020 Apr; 47(4):682-684. PubMed ID: 32389983
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Advanced Gastric Cancer with Multiple Liver Metastases Successfully Treated with Capecitabine, Cisplatin, and Trastuzumab].
Oneda Y; Tamura S; Murakami K; Takeno A; Kuwahara R; Akiyama Y; Sakamoto T; Inatome J; Naito A; Katsura Y; Ohmura Y; Kagawa Y; Egawa C; Takeda Y; Kato T
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2202-2204. PubMed ID: 28133269
[TBL] [Abstract][Full Text] [Related]
14. [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Kim Y; Hosoda Y; Nishino M; Okano M; Kawada J; Yamasaki M; Nagai K; Yasui M; Okuyama M; Tsujinaka T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1635-7. PubMed ID: 26805121
[TBL] [Abstract][Full Text] [Related]
15. [Complete Response of Liver Metastases from a HER2-Positive Gastric Cancer Treated with Combined S-1/Trastuzumab Chemotherapy].
Oae S; Shimada S; Takano Y; Seki J; Nakahara K; Maeda C; Takehara Y; Enami Y; Sawada N; Ishida F; Kudo S
Gan To Kagaku Ryoho; 2020 May; 47(5):831-834. PubMed ID: 32408330
[TBL] [Abstract][Full Text] [Related]
16. [A Case in Which Trastuzumab Combined Chemotherapy Was Effective for Recurrence of Post-Operative Gastric Cancer with Partial HER2 Overexpression].
Kimura A; Kagiya T; Yamauchi Y; Okano K; Sawano T; Ohashi M; Kato M; Hashimoto N; Umehara Y; Nishikawa S; Murata A; Takahashi K
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2027-2029. PubMed ID: 32157048
[TBL] [Abstract][Full Text] [Related]
17. [Laparoscopic Partial Hepatectomy for the Liver Metastasis of Gastric Cancer after Nab-Paclitaxel plus Ramucirumab Combination Therapy-A Case Report].
Chuman M; Takahashi Y; Tokito T; Maruyama M; Chino S; Ushiku H; Nakamura K; Naito M; Kondo Y; Yamazaki H; Nishi Y; Hiki N
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2065-2067. PubMed ID: 33468802
[TBL] [Abstract][Full Text] [Related]
18. [A Case of HER2-Positive Stage IV Advanced Gastric Cancer Treated with Chemotherapy Combined with Trastuzumab].
Takaya K; Takahashi R; Honma S; Horii S; Takahashi H; Hagiwara M; Chin M; Hashizume E
Gan To Kagaku Ryoho; 2016 Sep; 43(9):1113-6. PubMed ID: 27628555
[TBL] [Abstract][Full Text] [Related]
19. Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer.
Horita Y; Nishino M; Sugimoto S; Kida A; Mizukami A; Yano M; Arihara F; Matsuda K; Matsuda M; Sakai A
Anticancer Drugs; 2019 Jan; 30(1):98-104. PubMed ID: 30124494
[TBL] [Abstract][Full Text] [Related]
20. [Salvage Surgery for Unresectable Advanced Esophagogastric Junction Carcinoma with Multiple Liver Metastases after Successful Second-Line Treatment with Nab-Paclitaxel and Ramucirumab Following a Refractory Response to S-1 plus CDDP Therapy-A Case Report].
Fujita T; Shimizu Y; Dongping F; Yamamoto N; Kobayashi M; Iwabu H; Tsuji A
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1597-1600. PubMed ID: 33268735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
